Martínez Juan, Lampaya Verónica, Larraga Ana, Magallón Héctor, Casabona Diego
RNA Synthesis and Development Department, Certest Pharma, Certest Biotec, Zaragoza, Spain.
Front Mol Biosci. 2023 Sep 29;10:1248511. doi: 10.3389/fmolb.2023.1248511. eCollection 2023.
After the COVID-19 pandemic, messenger RNA (mRNA) has revolutionized traditional vaccine manufacturing. With the increasing number of RNA-based therapeutics, valuable new scientific insights into these molecules have emerged. One fascinating area of study is the formation of double-stranded RNA (dsRNA) during transcription (IVT) which is considered a significant impurity, as it has been identified as a major trigger in the cellular immune response pathway. Therefore, there is a growing importance placed to develop and optimize purification processes for the removal of this by-product. Traditionally, efforts have primarily focused on mRNA purification after IVT through chromatographic separations, with anion exchange and reverse phase chromatography emerging as effective tools for this purpose. However, to the best of our knowledge, the influence and significance of the quality of the linearized plasmid have not been thoroughly investigated. Plasmids production involves the growth of bacterial cultures, bacterial harvesting and lysis, and multiple filtration steps for plasmid DNA purification. The inherent complexity of these molecules, along with the multitude of purification steps involved in their processing, including the subsequent linearization and the less-developed purification techniques for linearized plasmids, often result in inconsistent batches with limited control over by-products such as dsRNA. This study aims to demonstrate how the purification process employed for linearized plasmids can impact the formation of dsRNA. Several techniques for the purification of linearized plasmids based on both, resin filtration and chromatographic separations, have been studied. As a result of that, we have optimized a chromatographic method for purifying linearized plasmids using monolithic columns with C4 chemistry (butyl chains located in the surface of the particles), which has proven successful for mRNAs of various sizes. This chromatographic separation facilitates the generation of homogeneous linearized plasmids, leading to mRNA batches with lower levels of dsRNA during subsequent IVT processes. This finding reveals that dsRNA formation is influenced not only by RNA polymerase and IVT conditions but also by the quality of the linearized template. The results suggest that plasmid impurities may contribute to the production of dsRNA by providing additional templates that can be transcribed into sequences that anneal with the mRNA molecules. This highlights the importance of considering the quality of plasmid purification in relation to dsRNA generation during transcription. Further investigation is needed to fully understand the mechanisms and implications of plasmid-derived dsRNA. This discovery could shift the focus in mRNA vaccine production, placing more emphasis on the purification of linearized plasmids and potentially saving, in some instances, a purification step for mRNA following IVT.
在新冠疫情之后,信使核糖核酸(mRNA)彻底改变了传统疫苗制造。随着基于RNA的疗法数量不断增加,人们对这些分子有了宝贵的新科学见解。一个引人入胜的研究领域是转录(IVT)过程中双链RNA(dsRNA)的形成,它被视为一种重要杂质,因为已被确定为细胞免疫反应途径中的主要触发因素。因此,开发和优化去除这种副产物的纯化工艺变得越来越重要。传统上,工作主要集中在IVT后通过色谱分离纯化mRNA,阴离子交换和反相色谱已成为实现这一目的的有效工具。然而,据我们所知,线性化质粒质量的影响和重要性尚未得到充分研究。质粒生产涉及细菌培养物的生长、细菌收获和裂解,以及用于纯化质粒DNA的多个过滤步骤。这些分子固有的复杂性,以及其处理过程中涉及的众多纯化步骤,包括随后的线性化以及针对线性化质粒不太成熟的纯化技术,常常导致批次不一致,对dsRNA等副产物的控制有限。本研究旨在证明用于线性化质粒的纯化过程如何影响dsRNA的形成。已经研究了基于树脂过滤和色谱分离的几种线性化质粒纯化技术。结果,我们优化了一种使用具有C4化学性质(丁基链位于颗粒表面)的整体柱纯化线性化质粒的色谱方法,该方法已被证明对各种大小的mRNA均成功。这种色谱分离有助于生成均匀的线性化质粒,从而在随后的IVT过程中产生dsRNA水平较低的mRNA批次。这一发现表明,dsRNA的形成不仅受RNA聚合酶和IVT条件的影响,还受线性化模板质量的影响。结果表明,质粒杂质可能通过提供额外的模板来促成dsRNA的产生,这些模板可转录成与mRNA分子退火的序列。这突出了在转录过程中考虑质粒纯化质量与dsRNA产生之间关系的重要性。需要进一步研究以充分了解质粒衍生dsRNA的机制和影响。这一发现可能会改变mRNA疫苗生产的重点,更加重视线性化质粒的纯化,并在某些情况下可能节省IVT后mRNA的一个纯化步骤。